Phosphatidylzidovudine

Latest Information Update: 30 Jun 1999

Price : ^*

* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

Originator Vical
Developer Gilead Sciences; Vical
Class Antivirals; Nucleosides; Phospholipids
Mechanism of Action RNA-directed DNA polymerase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued HIV infections

Most Recent Events

30 Jun 1999 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
21 Jul 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)
27 Mar 1995 New profile

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Login with a username/password associated to an account with a valid subscription
Contact your organization’s admin about adding this content to your AdisInsight subscription
Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.